Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06340802 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl

Name: A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl — clinical trial record (NCT06340802)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AURORA

StatusCompleted

PhaseNot applicable

SponsorSynergia Medical

Started2024-08-06

View on ClinicalTrials.gov ↗

This is an open label, single arm, interventional, prospective first in human study, designed to evaluate the safety of the NAO.VNS SYSTEM.

Amendment history 3 changes detected by DataLookout

2026-09-02

Trial completed

2026-09-02

Final enrollment: 5 participants (planned 10)

2026-09-02

Study completion confirmed: August 2026 (last estimated October 2026)

Trial Details

NCT Number	NCT06340802
Lead Sponsor	Synergia Medical
Conditions	Drug Resistant Epilepsy
Enrollment	5 participants
Start Date	2024-08-06
Primary Completion	2025-01-06 (estimated)
Study Completion	2026-08-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-01